New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg Telmisartan/25mg Hydrochlorothiazide) Approved By EU Commission

Boehringer Ingelheim announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus® 80/25 in all 27 EU member states. It will be launched in Germany and Denmark in the coming weeks, followed soon by Ireland, the United Kingdom and the rest of EU, and when approved also in other countries around the world.

More: continued here

Filed under: Hypertension on April 17th, 2008